Health Trials

About this trial

The aim of Re-Walk-Easy is to evaluate the effects of rehabilitation based on electrical stimulation on the motor performance of critically ill patients. The study will also investigate the pathophysiology of the two forms-the myopathic-predominant and the polyneuropathic-predominant variants-by examining the longitudinal progression of CIP and CIM and determining which form benefits more from electrical stimulation as a rehabilitative approach.

Eligibility criteria

Qualifiers

clinical diagnosis of tetra/paraparesis of peripheral origin as disclosed by ENG/EMG examination;

be independent before the episode of critical illness

Disqualifiers

history of previous comorbidity for ICU-AW;

previous known chronic polyneuropathy;

severe coagulopathy;

severe disorder of consciousness;

Trial design

Treatments tested in this trial

  • Rehabilitation protocol: FES
  • Rehabilitation protocol without FES
  • Rehabilitation protocol: FES

Treatment groups

72 Participants
are divided into 4 treatment groups

Locations

1
IRCCS Fondazione Don Carlo Gnocchi Onlus20148, Milan Italy

Sponsors and collaborators

Fondazione Don Carlo Gnocchi Onlus

Lead sponsor

Source ClinicalTrials.gov